Table 1 Clinical indexes in relation to DTL expression status in the liver samples

Age

 > 65

90

4

10

0.2543

0.7316

 ≤ 65

38

59

Gender

 Female

90

7

13

3.6161

0.1085

 Male

11

59

Survival status

 0

71

11

28

1.5935

0.2068

 1

5

27

Survival time

 > 3(year)

71

10

30

2.1738

0.1404

 ≤ 3(year)

3

25

Grade

 High-grade LIHC

90

0

31

29.8805

1.84E-07

 Middle-grade LIHC

15

38

 Low-grade LIHC

6

0

Cancer

 cancer

113

21

69

45.2856

1.70E-11

noncancerous

 Ki-67

88

23

0

7.2189

0.0072

 > 30%

2

29

 ≤ 30%

18

39

CD3

 ≤ 10%

87

18

26

13.6743

0.0002

 > 10%

3

40